ß-endorphin-immunoreactivity by a radioimmunoassay technique (Loeber et al. 1979) , which differed from the assay described above by the use of another antiserum (B4) directed at the midportion of the ß-endorphin molecule. The detection limit of this assay was 6 pg/tube.
. From the limited number of studies on human pituitary adenoma cells, it seems that ACTH and ß-endorphin/ß-LPH are concomitantly secreted Mashiter et al. 1980 ; Shibasaki & Masui 1982) . Recently Vale et al. ( 1981 ) reported the isolation and characterization of CRF from ovine hypothalamus. This peptide stimulates the release of ACTH (and ß-endorphin) from the pituitary of man and rat both in vivo (Grossman et al. 1982; Orth et al. 1982; Rivier et al. 1982 ) and in vitro (Chan et al. 1982; White et al. 1982; Vale et al. 1981) .
In the present study we ß-endorphin-immunoreactivity by a radioimmunoassay technique (Loeber et al. 1979) , which differed from the assay described above by the use of another antiserum (B4) directed at the midportion of the ß-endorphin molecule. The detection limit of this assay was 6 pg/tube.
Cross-reactivity (on a mass basis) in this system: ß-LPH 100%; -endorphin 450%; ct-endorphin 250%; metenkephalin 0.2%; ß-endorphini_2i 240%. All synthetic peptides were synthesized and purified by Drs. H. M.
Greven and J. van Nispen (Organon, Oss). (Fig. 3) . The ratio of secreted hormone over intracellular hormone was identical for these cell concentrations (about 0.07). (Table 4) . A lower concen¬ tration of bromocriptine (10 nM) had no effect at all (data not shown). Dexamethasone (0.1 µ ) completely blocked the stimulation of hormone secretion by 10 nM CRF during a 4 h incubation (Table 3) .
Gel chromatography Gel chromatography of cell culture media yielded only two peaks of ß-endorphin LIR. The first co-eluted with ß-LPH and the second with ß-endor¬ phin. Four column runs of media from untreated cells (patient 2, day 4, Table 3 ) yielded a mean ratio of ß-LPH: ß-endorphin of 1:2.00 ± 0.38 (so) (Fig.   4B ). Chromatography of CRF-, and LVP-treated media did not show any significant changes in ß-LPH: ß-endorphin ratio. For LVP-treated cells the mean ß-LPH: ß-endorphin ratio was 1:2.10 ± 0.15 (n = 3) and for CRF (10 nM)-treated cells the mean ratio was 1:2.15 ± 0.58 (n = 3) (Fig. 4A) .
HPLC fractionation Fig. 5 shows the HPLC profiles of peptides ob- tained from the culture media monitored for ß-endorphin LIR. One major peak eluted at the position of intact ß-endorphin (ßE1-31). Other peaks were detected co-eluting wiht a-endorphin (ß 1-16), -endorphin (ßEl-17) and ßEl-21 (Fig.   5B ). CRF (10 nM) caused a simultaneous stimula¬ tion of the release of all these peptides (Fig. 5 A) compared with control (Fig. 5B) ßh-endorphin (1-31) and the ß-endorphin fragments: 6-17 (des-enkephalin-y-endorphin), 1-16 (a-endorphin), 2-17 (des-tyrosine-y-endorphin), [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] ( -endorphin) (Vale et al. 1981) and mouse (Hook et al. 1982) corticotrophs. So 
